Gossamer Bio, Inc. (GOSS)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$76.9M
Stockholders' Equity
-$94.0M
Cash & Equivalents
$41.1M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, Gossamer Bio, Inc. reported revenue of $9.2M, net income of $16.9M, and total assets of $76.9M. Every figure below is taken directly from Gossamer Bio, Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2022–FY2025 · as reported

$114.7M-$57.3M-$229.4M
FY2022FY2023FY2024FY2025
Revenue$48.5MNet income-$170.4M
FY2022 revenue
$0
FY2025 revenue
$48.5M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$48.5M-$170.4M
FY2024$114.7M-$56.5M
FY2023$0-$179.8M
FY2022$0-$229.4M
FY2021—-$234.0M
FY2020—-$243.4M
FY2019—-$180.3M
FY2018—-$147.0M
FY2017—-$6.8M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 28, 2026on EDGAR ↗
8-KSep 28, 2026on EDGAR ↗
8-KSep 23, 2026on EDGAR ↗
8-KSep 16, 2026on EDGAR ↗
DEF 14ASep 16, 2026on EDGAR ↗
8-KSep 11, 2026on EDGAR ↗
8-KSep 9, 2026on EDGAR ↗
8-KSep 3, 2026on EDGAR ↗
8-KAug 26, 2026on EDGAR ↗
8-KAug 21, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$76.9Msource ↗
Stockholders’ Equity-$94.0Msource ↗
Cash & Equivalents$41.1Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$9.2Msource ↗
Net Income$16.9Msource ↗
Operating Income-$26.1Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$26.4Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.08source ↗
EPS (basic)$0.05source ↗
Shares Outstanding488.8Msource ↗
Cash from Operations-$39.4Msource ↗
Cash from Financing-$3.1Msource ↗
Cash from Investing$42.7Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

No open-market Form 4 transactions filed in the last 180 days.

Restatement history

Point-in-time

No material restatements detected across 205 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches GOSS’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/GOSS

MCP tool: get_sec_fundamentals ticker=GOSS

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/GOSS/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=GOSS as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/GOSS/history

MCP tool: get_fundamentals_history ticker=GOSS

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/GOSS

MCP tool: get_financial_health ticker=GOSS

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.